Target intelligence / Profile preview

Capicua transcriptional repressor pseudogene 7 (CICP7)

Target: CICP7
Molecular classification: Pseudogene

Overview

Capicua transcriptional repressor pseudogene 7 (CICP7) is a non-coding DNA sequence in the human genome that is classified as a processed pseudogene[5]. Pseudogenes like CICP7 originate from duplication or retrotransposition of parent genes but do not produce functional proteins. While some pseudogenes can regulate their parental genes via RNA-mediated effects, there is currently no evidence that CICP7 has significant biological or disease-related functions. Its parental gene, capicua transcriptional repressor (CIC), is a conserved transcriptional repressor important for normal development and tumor suppression, but this does not extend to its pseudogene CICP7[4][5]. Given its lack of protein-coding capacity, CICP7 is not a receptor, enzyme, or valid drug target.

Other names: CICP7Capicua transcriptional repressor pseudogene 7

Mechanism of action

None documented (No known drugs or experimental therapies target this pseudogene)

Biological functions

As a pseudogene, CICP7 does not encode an active protein. Unlike the parental CIC gene, it is not known to act as a transcription factor or have regulatory functions[1][5].

Disease associations

No established disease association for CICP7.By analogy with other pseudogenes (see Table in search result [3]), some pseudogenes play roles as microRNA sponges or competitive endogenous RNAs (ceRNAs) that modulate gene expression, but there is no specific evidence for CICP7[3].

Safety considerations

None documented (as it is not a therapeutic target nor functionally active)

Interacting drugs

None documented

Biomarkers

None documented

Beyond the preview

Go deeper on Capicua transcriptional repressor pseudogene 7 (CICP7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Capicua transcriptional repressor pseudogene 7 (CICP7).

Explore the full profile